Opinion: Do not treat

Ludwig, Wesley W.; Ziemba, Justin; Matlaga, Brian R.

doi:10.1590/s1677-5538.ibju.2016.02.04

Cited by 2 publications

(2 citation statements)

References 13 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While the recommended pharmacologic dissolution and expulsive therapy seem reasonably safe, 50 the evidence base involving treatment of this population of interest is yet to be made comprehensive and definitive. Moreover, urosurgical treatment modalities in this context have been demonstrated to be both ineffective 57,59 and outright detrimental in the long run. 60…”

Section: Possible Implications Of Findings In Managing Gout Patients mentioning

confidence: 99%

<p>Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital</p>

Tee

Lustre

Abrilla

et al. 2020

RRU

View full text Add to dashboard Cite

Context: While urolithiasis is epidemiologically and mechanistically linked to gout, urologic stone disease is not actively investigated in gout patients. Prevalence estimates on the coexistence of urolithiasis in gout have mostly relied on clinical history alone. Purpose: To estimate the prevalence of urolithiasis among adult Filipinos with primary gout through clinical history and ultrasonography. Patients and Methods: Patients diagnosed with primary gout were consecutively enrolled from outpatient clinics of the University of the Philippines Manila-Philippine General Hospital. Clinical data including sex; current age; age at diagnosis, duration of and attack frequency of gout; comorbidities such as hypertension, chronic kidney disease, type 2 diabetes mellitus, and dyslipidemia; personal history of urolithiasis; family history of gout; presence of tophus and laboratory samples to assess general kidney function, serum uric acid level, and urine pH were obtained from each patient who was subsequently subjected to ultrasonographic examination for urolithiasis. Lithiasic and non-lithiasic patients were identified and compared aggregately in terms of the aforementioned features. Results: We recruited 121 patients, 86.8% of whom are male, and 37 (30.6%; 95% CI=23.1-39.3%) were identified to have urolithiasis of which only 12 (9.9%) had history consistent with urolithiasis and 30 (24.8%) were diagnosed solely through ultrasonography. None of the variables of interest were found to be statistically associated (P>0.05) with urologic stone formation. Conclusion: Urolithiasis among adult Filipino patients with primary gout was found to be more prevalent in this study than previous estimates, which were based only on clinical history. We discovered that 25/37 (67.6%) of patients with urolithiasis denied history of urologic stone.

show abstract

Section: Possible Implications Of Findings In Managing Gout Patients mentioning

confidence: 99%

<p>Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital</p>

Tee

Lustre

Abrilla

et al. 2020

RRU

View full text Add to dashboard Cite

show abstract

“…A prospective-randomized study with asymptomatic caliceal stones <15 mm did not find any statistical advantage of ESWL over observation in terms of stone free rate (SFR), quality-of-life, kidney function and symptoms during a 2.2-year follow-up [17]. Therefore, watchful waiting can be suggested with yearly follow-up examinations over a period of 2-3 years.Asymptomatic calyceal stones may be observed but there is a higher risk of symptoms and a need for intervention within 5 yr. [18,19].…”

Section: Kidney Stone Diseasementioning

confidence: 99%

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

2018

ARC Journal of Urology

View full text Add to dashboard Cite

The prevalence of kidney stone disease, chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH) increases around the world. Long-term medications and surgical procedures for these non-life-threatening chronic conditions can develop serious side effects and complications. At the same time, Thermobalancing therapy (TT) with Dr Allen's therapeutic Device (DATD) has shown its high effectiveness in the treatment of chronic internal diseases. Discussion at many international conferences in 2017-2018 was aimed at treating various chronic non-malignant diseases with the help of Thermobalancing therapy, such as BPH, CP/CPPS, kidney stones and cardiovascular diseases. In the conferences were presented cases of TT with DATD of patients with kidney stone disease that confirm the ability of DATD to dissolve any type and size of kidney stone; discussed the outcomes from the clinical trials of TT in 124 men with BPH and 45 patients with CP/CPPS, before and after 6-month period they used DATD. The assured results of the cases and clinical trials reveal that TT with DATD treats the cause of kidney stone disease, CP/CPPS and BPH. Implementation of this therapy is needed today, as it helps patients avoid long-term drugs and surgical procedures, including extracorporeal shock wave lithotripsy (ESWL) with their risks and complications. In addition, it is a cost-effective solution. Therefore, conference participants proposed that TT with DATD should be included in the Guidance for health professionals.

show abstract

Opinion: Do not treat

Cited by 2 publications

References 13 publications

<p>Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital</p>

<p>Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital</p>

Treatment of Kidney Stone Disease, Benign Prostatic Hyperplasia and Chronic Prostatitis with Thermobalancing Therapy should be listed in the Guidance for Health Professionals

Contact Info

Product

Resources

About